To date, we initiated collaborations and agreements with the leading large pharma and biotech companies around the world for in vivo, preclinical, and clinical development of:
Winner 2021 ViE Best Central/Specialty Laboratory
Recognition for Reference Assay Development in the COVID-19 Field
COVID-19: Timeline of Events
Nexelis and PHE Porton Down played a determinant role in the struggle against SARS-Cov-2, partnering with multiple multinational pharmaceutical companies, innovative biotechnology companies, governmental and nongovernmental bodies including BMGF, CEPI, and BARDA. We developed reference vaccine and drug efficacy assessment assays and transferred their technology to a network of clinical testing laboratories all over the world.
During these 18 months, Nexelis and PHE Porton Down supported more than 60 COVID-19-related development projects and testing of more than 50,000 samples per month in BSL-2 and BSL-3 laboratories.